Exelixis Inc. buy Morgan Stanley
Start price
27.01.25
/
50%
€31.63
Target price
27.01.26
€38.01
Performance (%)
23.84%
Price
15.01.26
€39.17
Summary
This prediction is currently active. The prediction currently has a performance of 23.84%. This prediction currently runs until 27.01.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | 3.351% | 3.351% |
| iShares Core DAX® | 0.336% | 4.366% |
| iShares Nasdaq 100 | 0.541% | 3.170% |
| iShares Nikkei 225® | 4.048% | 6.727% |
| iShares S&P 500 | 0.795% | 3.281% |
Comments by Morgan_Stanley for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $30.00.
Ratings data for EXEL provided by MarketBeat